Does multilocus inherited neoplasia alleles syndrome have severe clinical expression?
暂无分享,去创建一个
C. Lázaro | G. Capellá | L. Feliubadaló | J. Brunet | A. Izquierdo | M. Navarro | S. González | E. Tornero | O. Campos | M. Pineda | Ángela Velasco | J. Del Valle | G. Vargas | A. Stradella | Paula Rofes | Èlia Grau Garces | Judith Balmaña-Gelpi | J. del Valle | S. González | Olga Campos
[1] William J. Astle,et al. Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes , 2018, American journal of human genetics.
[2] Robert Huether,et al. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer , 2017, JAMA oncology.
[3] C. Lázaro,et al. A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape , 2017, Scientific Reports.
[4] D. Sussman,et al. Co-occurrence of Lynch syndrome and juvenile polyposis syndrome confirmed by multigene panel testing , 2017, Familial Cancer.
[5] Olufunmilayo I. Olopade,et al. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women , 2016, Breast Cancer Research.
[6] R. Scott,et al. Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Vijai Joseph,et al. Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] L. Happerfield,et al. Multilocus Inherited Neoplasia Alleles Syndrome: A Case Series and Review. , 2016, JAMA oncology.
[9] H. Rehm,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[10] M. Robson,et al. American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility. , 2010, Journal of Clinical Oncology.
[11] Karla Bowles,et al. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next‐generation sequencing with a 25‐gene panel , 2015, Cancer.
[12] A. Duval,et al. Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘Care for CMMRD’ (C4CMMRD) , 2014, Journal of Medical Genetics.
[13] Michael Krawczak,et al. Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease , 2013, Human Genetics.
[14] A. W. van der Vaart,et al. CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women , 2011, Journal of Medical Genetics.
[15] W. Foulkes,et al. Inherited susceptibility to common cancers. , 2008, The New England journal of medicine.
[16] W. Foulkes,et al. BRCA1 and BRCA2: 1994 and beyond , 2004, Nature Reviews Cancer.